| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARTICLE |
German Diabetes Research Institute at the University of Duesseldorf, Duesseldorf D-40225, Germany
Address all correspondence and requests for reprints to: J. Seissler, M.D., German Diabetes Research Institute, University of Duesseldorf, Auf'm Hennekamp 65, D-40225 Duesseldorf, Germany. E-mail: .
Cytokines released from activated antigen-presenting cells and T-lymphocytes are crucially involved in the pathogenesis of type 1 diabetes. Previous studies have shown that proinflammatory cytokines play an important role in the induction of autoimmunity and ß-cell damage. Inhibition of insulin expression has been described, but their effects on other major target autoantigens, such as the tyrosine phosphatase-like protein IA-2, is not known. In the present study, we established sensitive real-time RT-PCR to measure IA-2, insulin, and inducible nitric oxide (NO) synthase (iNOS) mRNA expression. Rat insulinoma INS-1 cells were stimulated with IL-1ß, TNF-
, interferon (IFN)-
, and IL-2 as well as with two combinations of these cytokines (C1: IL-1ß + TNF-
+ IFN-
; C2: TNF-
+ IFN-
). Treatment with IL-1ß, TNF-
, or IFN-
alone caused a significant down-regulation of IA-2 and insulin mRNA levels in a time and dose-dependent manner, whereas IL-2 had no effect. Exposure to cytokine combinations strongly potentiates the inhibitory effects. Incubation of cells with C1 and C2 for 24 h induces a significant inhibition of IA-2 mRNA levels by 78% and 58%, respectively. Under these conditions, an up to 5 x 104-fold increase of iNOS gene expression was observed. The hypothesis that the formation of NO is involved in IA-2 regulation was confirmed by the finding that the coincubation of C1 with 4 mM L-NG-monomethyL-L-arginine, an inhibitor of the iNOS, partly reversed the down-regulation of IA-2. Further, incubation with the synthetic NO-donor S-nitroso-N-acetyl-D-L-penicillamine significantly decreased IA-2 mRNA level to 51% of basal levels. In conclusion, we have demonstrated for the first time that IL-1ß, TNF-
, and IFN-
exert a strong inhibitory effect on expression of the diabetes autoantigen IA-2. The action of IL-1ß may be partly mediated by the activation of the NO pathway.
This article has been cited by other articles:
![]() |
S. Torii, N. Saito, A. Kawano, N. Hou, K. Ueki, R. N. Kulkarni, and T. Takeuchi Gene Silencing of Phogrin Unveils Its Essential Role in Glucose-Responsive Pancreatic {beta}-Cell Growth Diabetes, March 1, 2009; 58(3): 682 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nitescu, E. Grimberg, S.-E. Ricksten, N. Marcussen, H. Nordlinder, and G. Guron Effects of thrombin inhibition with melagatran on renal hemodynamics and function and liver integrity during early endotoxemia Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1117 - R1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Trajkovski, H. Mziaut, A. Altkruger, J. Ouwendijk, K.-P. Knoch, S. Muller, and M. Solimena Nuclear translocation of an ICA512 cytosolic fragment couples granule exocytosis and insulin expression in {beta}-cells J. Cell Biol., December 20, 2004; 167(6): 1063 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. I. Mendez, Y.-H. Chung, H.-S. Jun, and J.-W. Yoon Immunoregulatory Role of Nitric Oxide in Kilham Rat Virus-Induced Autoimmune Diabetes in DR-BB Rats J. Immunol., July 15, 2004; 173(2): 1327 - 1335. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |